Xinzhi Medical is a research and development company of cardiovascular interventional therapy, dedicated to promoting the technological innovation of cardiovascular interventional therapy. And drug coating technology as a platform, to become a domestic provider of interventional non-implantation solutions. Recently completed a strategic financing of 8.66 million yuan, and the investor is Baixinan. The post-investment valuation is 100 million yuan, accounting for 8.66%.
This article is reproduced from: https://www.itjuzi.com/investevent/13295423
This site is for inclusion only, and the copyright belongs to the original author.